Nakazawa-Miklasevica M - Search Results

1

An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3.

Pirsko V, Cakstina I, Priedite M, Dortane R, Feldmane L, Nakazawa-Miklasevica M, Daneberga Z, Gardovskis J, Miklasevics E. Pirsko V, et al. Among authors: nakazawa miklasevica m. Medicina (Kaunas). 2018 Mar 30;54(2):11. doi: 10.3390/medicina54020011. Medicina (Kaunas). 2018. PMID: 30344242 Free PMC article.

2

BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.

Berzina D, Nakazawa-Miklasevica M, Zestkova J, Aksenoka K, Irmejs A, Gardovskis A, Kalniete D, Gardovskis J, Miklasevics E. Berzina D, et al. BMC Med Genet. 2013 Jun 14;14:61. doi: 10.1186/1471-2350-14-61. BMC Med Genet. 2013. PMID: 23767878 Free PMC article.

3

Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.

Maksimenko J, Irmejs A, Nakazawa-Miklasevica M, Melbarde-Gorkusa I, Trofimovics G, Gardovskis J, Miklasevics E. Maksimenko J, et al. Oncol Lett. 2014 Jan;7(1):278-284. doi: 10.3892/ol.2013.1684. Epub 2013 Nov 14. Oncol Lett. 2014. PMID: 24348864 Free PMC article.

4

High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.

Kalniete D, Nakazawa-Miklaševiča M, Štrumfa I, Āboliņš A, Irmejs A, Gardovskis J, Miklaševičs E. Kalniete D, et al. Hered Cancer Clin Pract. 2015 Feb 8;13(1):7. doi: 10.1186/s13053-015-0028-z. eCollection 2015. Hered Cancer Clin Pract. 2015. PMID: 25705321 Free PMC article.

5

Impact of KRAS variant rs61764370 on breast cancer morbidity.

Ustinova M, Daneberga Z, Bērziņa D, Nakazawa-Miklaševiča M, Maksimenko J, Gardovskis J, Miklaševičs E. Ustinova M, et al. Among authors: nakazawa miklasevica m. Exp Oncol. 2015 Dec;37(4):292-4. Exp Oncol. 2015. PMID: 26710843

6

Chromothripsis and progression-free survival in metastatic colorectal cancer.

Skuja E, Kalniete D, Nakazawa-Miklasevica M, Daneberga Z, Abolins A, Purkalne G, Miklasevics E. Skuja E, et al. Among authors: nakazawa miklasevica m. Mol Clin Oncol. 2017 Feb;6(2):182-186. doi: 10.3892/mco.2017.1123. Epub 2017 Jan 2. Mol Clin Oncol. 2017. PMID: 28357089 Free PMC article.

7

Deletions in metastatic colorectal cancer with chromothripsis.

Skuja E, Butane D, Nakazawa-Miklasevica M, Daneberga Z, Purkalne G, Miklasevics E. Skuja E, et al. Among authors: nakazawa miklasevica m. Exp Oncol. 2019 Dec;41(4):323-327. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-4.13841. Exp Oncol. 2019. PMID: 31868331

8

Bladder cancer trends in Latvia during 1990-2017: incidence, mortality, and survival rates.

Bitiņa-Barlote Ē, Plonis J, Cauce V, Vjaters E, Gardovskis J, Miklaševičs E, Nakazawa-Miklaševiča M. Bitiņa-Barlote Ē, et al. Among authors: nakazawa miklasevica m. Cent European J Urol. 2021;74(1):14-23. doi: 10.5173/ceju.2021.0266.R2. Epub 2021 Feb 18. Cent European J Urol. 2021. PMID: 33976911 Free PMC article.

9

Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder.

Daneberga Z, Nakazawa-Miklasevica M, Berga-Svitina E, Murmane D, Isarova D, Cupane L, Masinska M, Nartisa I, Lazdane A, Miklasevics E. Daneberga Z, et al. Among authors: nakazawa miklasevica m. Nord J Psychiatry. 2022 Oct;76(7):523-529. doi: 10.1080/08039488.2021.2014954. Epub 2021 Dec 22. Nord J Psychiatry. 2022. PMID: 34935590

10

Survival rates of familial and sporadic prostate cancer patients.

Plonis J, Nakazawa-Miklasevica M, Malevskis A, Vaganovs P, Pildava S, Vjaters E, Gardovskis J, Miklasevics E. Plonis J, et al. Exp Oncol. 2015 Jun;37(2):154-5. Exp Oncol. 2015. PMID: 26112946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page